DOI: 10.1016/j.phymed.2013.10.024, Upadya, H., Prabhu, S., Prasad, A
Availability is phased: it is rolling out on private prescription during the second half of 2026 and is not yet available on the NHS
The Emerging Evidence: GLP-1 Receptor Agonists and Cancer Risk Reduction The oncological implications of GLP-1 therapy represent one of the most actively researched frontiers in metabolic medicine
Since the initial investigations began in the 1960s, scientists have explored its possible roles in sleep regulation, stress adaptation, pain modulation, and neuroendocrine function
You are actively engaged in a weight management program (including diet and exercise) and want to support your body's fat metabolism